AR051295A1 - Derivados de pirimidina y su uso - Google Patents
Derivados de pirimidina y su usoInfo
- Publication number
- AR051295A1 AR051295A1 ARP050103930A ARP050103930A AR051295A1 AR 051295 A1 AR051295 A1 AR 051295A1 AR P050103930 A ARP050103930 A AR P050103930A AR P050103930 A ARP050103930 A AR P050103930A AR 051295 A1 AR051295 A1 AR 051295A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- cycloalkyl
- trifluoromethoxy
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Procedimientos para su preparacion, a su uso para el tratamiento y/o la profilaxis de enfermedades, así como a su uso para la preparacion de medicamentos para el tratamiento y/o profilaxis de enfermedades, preferentemente para el tratamiento y/o la prevencion de enfermedades cardiovasculares, en particular, dislipidemias, arteriosclerosis, insuficiencia cardíaca, trombosis y síndrome metabolico. Reivindicacion 1: Compuesto de formula (1) en la que A representa O o S, uno de los miembros de anillo D y E representa N y el otro CH; Z representa (CH2)m, O o N-R9, en los que m significa el numero 0, 1 o 2 y R9 significa H o alquilo C1-6, n representa el numero 0, 1 o 2; R1 representa arilo C6-10 o heteroarilo de 5 a 10 miembros, que respectivamente pueden estar sustituidos hasta cuatro veces, de manera igual o diferente, por sustituyentes seleccionados entre la serie de halogeno, nitro, ciano, alquilo C1-6, que a su vez puede estar sustituido por hidroxilo, cicloalquilo C3-8, fenilo, hidroxi, alcoxi C1-6, trifluorometilo, trifluorometoxi, amino, mono- y di-alquil C1-6-amino, R10-C(O)-NH-, R11-C(O)-, R12R13N-C(O)-NH- y R14R15N-C(O)-, en los que R10 significa H, alquilo C1-6, cicloalquilo C3-8, fenilo o alcoxi C1-6; R11 significa H, alquilo C1-6, cicloalquilo C3-8, fenilo, hidroxilo o alcoxi C1-6 y R12, R13, R14 y R15 son iguales o diferentes e, independientemente entre sí, significan H, alquilo C1-6, cicloalquilo C3-8 o fenilo, o R1 representa cicloalquilo C3-7 o un heterociclo de 5 o 6 miembros, que respectivamente pueden estar sustituidos hasta dos veces, de manera igual o diferente, por alquilo C1-6, alcoxi C1-6, trifluorometilo o trifluorometoxi, o la agrupacion -Z-R1 representa un grupo de formula (2) en la que R18 significa H, halogeno, alquilo C1-6, alcoxi C1-6, trifluorometilo o trifluorometoxi y * significa el sitio de enlace; R2 representa H, arilo C6-10, alquilo C1-6, alquenilo C2-6 o alquinilo C2-6, pudiendo el alquilo, alquenilo y alquinilo estar respectivamente sustituidos por trifluorometilo, alcoxi C1-6, trifluorometoxi, F, ciano, cicloalquilo C3-6, arilo C6-10 o heteroarilo de 5 o 6 miembros, pudiendo todos los grupos arilo y heteroarilo citados estar a su vez respectivamente sustituidos hasta tres veces, de manera igual o diferente, por sustituyentes seleccionados entre la serie de halogeno, nitro, ciano, alquilo C1-6, hidroxi, alcoxi C1-6, trifluorometilo y trifluorometoxi; R3 y R4 son iguales o diferentes e, independientemente entre sí, representan H, alquilo C1-6, alquenilo C2-6, alcoxi C1-6, trifluorometilo, trifluorometoxi o halogeno; R5 y R6 son iguales o diferentes e, independientemente entre sí, representan H, alquilo C1-6, alcoxi C1-6 o fenoxi, o juntos con el átomo de C al que están unidos, forman un anillo cicloalquilo C3-8; R7 representa un grupo de formula -NHR16 u -OR17, en el que R16 significa H, alquilo C1-6 o alquil C1-6-sulfonilo y R17 significa H o representa un grupo hidrolizable, que puede transformarse en el ácido carboxílico correspondiente, y R8 representa H o alquilo C1-6, así como sus sales, solvatos y los solvatos de las sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004046623A DE102004046623A1 (de) | 2004-09-25 | 2004-09-25 | Neue Pyrimidin-Derivate und ihre Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051295A1 true AR051295A1 (es) | 2007-01-03 |
Family
ID=35063041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103930A AR051295A1 (es) | 2004-09-25 | 2005-09-20 | Derivados de pirimidina y su uso |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20080261990A1 (es) |
| EP (1) | EP1797045A1 (es) |
| JP (1) | JP2008514559A (es) |
| KR (1) | KR20070055621A (es) |
| CN (1) | CN101065364A (es) |
| AR (1) | AR051295A1 (es) |
| AU (1) | AU2005287589A1 (es) |
| BR (1) | BRPI0517327A (es) |
| CA (1) | CA2582492A1 (es) |
| DE (1) | DE102004046623A1 (es) |
| EC (1) | ECSP077340A (es) |
| GT (1) | GT200500266A (es) |
| IL (1) | IL182136A0 (es) |
| MA (1) | MA28882B1 (es) |
| MX (1) | MX2007003428A (es) |
| NO (1) | NO20072051L (es) |
| PE (1) | PE20060657A1 (es) |
| RU (1) | RU2007115215A (es) |
| SV (1) | SV2007002235A (es) |
| TW (1) | TW200628451A (es) |
| UY (1) | UY29127A1 (es) |
| WO (1) | WO2006032384A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2591783A1 (en) | 2007-04-13 | 2013-05-15 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| KR100813387B1 (ko) * | 2007-06-26 | 2008-03-12 | 신명곤 | 부형제 첨가없이 인삼농축액으로 유동성 및 저장성이우수한 인삼농축액환 제조 방법 |
| ES2552657T3 (es) | 2010-05-26 | 2015-12-01 | Satiogen Pharmaceuticals, Inc. | Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias |
| WO2012030165A2 (ko) | 2010-08-31 | 2012-03-08 | 서울대학교산학협력단 | P P A R δ 활성물질의 태자재프로그래밍용도 |
| MX363161B (es) | 2011-10-28 | 2019-03-13 | Lumena Pharmaceuticals Inc | Inhibidores de la recirculación de ácidos biliares para el tratamiento de hipercolemia y enfermedad hepática colestásica. |
| US20140243281A1 (en) | 2011-10-28 | 2014-08-28 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| CN103130732A (zh) * | 2011-11-22 | 2013-06-05 | 上海博康精细化工有限公司 | 3,5-二甲基-4-氯甲基异噁唑的制备方法 |
| KR20230152818A (ko) | 2013-03-15 | 2023-11-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제 |
| CA2907214A1 (en) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease |
| WO2017190050A1 (en) * | 2016-04-28 | 2017-11-02 | Cornell University | Inhibitors of soluble adenylyl cyclase |
| BR112021015799A2 (pt) | 2019-02-12 | 2022-01-18 | Mirum Pharmaceuticals Inc | Métodos para aumentar o crescimento em pacientes pediátricos com doença colestática do fígado |
| CN115598267B (zh) * | 2022-12-13 | 2023-05-09 | 山东省食品药品检验研究院 | 一种格列齐特中潜在遗传毒性杂质的分析方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE368037T1 (de) * | 1999-04-28 | 2007-08-15 | Sanofi Aventis Deutschland | Di-aryl-säurederivate als ppar rezeptor liganden |
| GB0214254D0 (en) * | 2002-06-20 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
-
2004
- 2004-09-25 DE DE102004046623A patent/DE102004046623A1/de not_active Withdrawn
-
2005
- 2005-09-10 CN CNA2005800404273A patent/CN101065364A/zh active Pending
- 2005-09-10 AU AU2005287589A patent/AU2005287589A1/en not_active Abandoned
- 2005-09-10 MX MX2007003428A patent/MX2007003428A/es not_active Application Discontinuation
- 2005-09-10 US US11/663,813 patent/US20080261990A1/en not_active Abandoned
- 2005-09-10 RU RU2007115215/04A patent/RU2007115215A/ru not_active Application Discontinuation
- 2005-09-10 BR BRPI0517327-2A patent/BRPI0517327A/pt not_active Application Discontinuation
- 2005-09-10 CA CA002582492A patent/CA2582492A1/en not_active Abandoned
- 2005-09-10 KR KR1020077009268A patent/KR20070055621A/ko not_active Application Discontinuation
- 2005-09-10 EP EP05782757A patent/EP1797045A1/de not_active Withdrawn
- 2005-09-10 WO PCT/EP2005/009734 patent/WO2006032384A1/de active Application Filing
- 2005-09-10 JP JP2007532798A patent/JP2008514559A/ja active Pending
- 2005-09-20 AR ARP050103930A patent/AR051295A1/es unknown
- 2005-09-23 PE PE2005001101A patent/PE20060657A1/es not_active Application Discontinuation
- 2005-09-23 TW TW094132926A patent/TW200628451A/zh unknown
- 2005-09-23 SV SV2005002235A patent/SV2007002235A/es not_active Application Discontinuation
- 2005-09-23 UY UY29127A patent/UY29127A1/es not_active Application Discontinuation
- 2005-09-23 GT GT200500266A patent/GT200500266A/es unknown
-
2007
- 2007-03-22 IL IL182136A patent/IL182136A0/en unknown
- 2007-03-23 EC EC2007007340A patent/ECSP077340A/es unknown
- 2007-03-30 MA MA29787A patent/MA28882B1/fr unknown
- 2007-04-20 NO NO20072051A patent/NO20072051L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200628451A (en) | 2006-08-16 |
| NO20072051L (no) | 2007-06-07 |
| MA28882B1 (fr) | 2007-09-03 |
| RU2007115215A (ru) | 2008-11-10 |
| CA2582492A1 (en) | 2006-03-30 |
| US20080261990A1 (en) | 2008-10-23 |
| CN101065364A (zh) | 2007-10-31 |
| PE20060657A1 (es) | 2006-08-12 |
| DE102004046623A1 (de) | 2006-03-30 |
| UY29127A1 (es) | 2006-04-28 |
| ECSP077340A (es) | 2007-04-26 |
| BRPI0517327A (pt) | 2008-10-07 |
| EP1797045A1 (de) | 2007-06-20 |
| IL182136A0 (en) | 2007-07-24 |
| AU2005287589A1 (en) | 2006-03-30 |
| SV2007002235A (es) | 2007-03-20 |
| MX2007003428A (es) | 2008-03-13 |
| JP2008514559A (ja) | 2008-05-08 |
| GT200500266A (es) | 2006-05-11 |
| KR20070055621A (ko) | 2007-05-30 |
| WO2006032384A1 (de) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051295A1 (es) | Derivados de pirimidina y su uso | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| AR069417A1 (es) | Piperidinas heteroaril - sustituidas | |
| AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
| AR075868A1 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
| AR086144A1 (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
| AR058703A1 (es) | Triazolopiridazinas inhibidoras de tirosinquinasas, metodo de preparacion, composiciones farmaceuticas que las contienen y usos terapeuticos en el tratamiento del cancer | |
| AR081058A1 (es) | Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer. | |
| AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| AR084768A1 (es) | Moduladores de la senda de complemento y usos de los mismos | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR051485A1 (es) | Pirazolo pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| AR067327A1 (es) | Derivados de piperidina / piperazina | |
| AR059831A1 (es) | Derivados de cromanol sustituidos | |
| AR060401A1 (es) | Derivados de cromen-2-ona | |
| AR049116A1 (es) | Derivados de piperazina y usos para controlar pestes. | |
| AR063800A1 (es) | Derivados de acido nicotinico, composiciones farmaceuticas que las contienen y metodos de uso de los mismos | |
| AR048004A1 (es) | Nuevos esteres de quinuclidina cuaternizados | |
| AR065891A1 (es) | Derivados de piridina y pirimidina como antagonistas del mglur2 | |
| AR064424A1 (es) | Derivados sustituidos de 1-oxo-ftalazinas y 1-oxo-pirido-piridazinas,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar enfermedades inflamatorias y alergicas del tracto respiratorio. | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR097755A1 (es) | Derivados sustituidos de fenilalanina como moduladores del factor xia | |
| AR048195A1 (es) | Uso de un derivado de fenotiazina para la prevencion y/o tratamiento de la perdida de audicion | |
| AR063577A1 (es) | Derivados 8- piperidinil - pirimido [1 2 a] pirimidin -6-ona y 8- piperidinil-2- pirimidinil- pirimido [1,2-a] pirimidin -6- ona sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |